Compare ITGR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITGR | HAE |
|---|---|---|
| Founded | 1970 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 2000 | 1996 |
| Metric | ITGR | HAE |
|---|---|---|
| Price | $86.41 | $64.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $91.14 | $86.00 |
| AVG Volume (30 Days) | ★ 954.6K | 876.4K |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.54 |
| EPS | ★ 2.89 | 2.46 |
| Revenue | ★ $1,853,637,000.00 | $910,373,000.00 |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $8.25 | $5.46 |
| P/E Ratio | $30.03 | ★ $26.57 |
| Revenue Growth | ★ 7.98 | N/A |
| 52 Week Low | $62.00 | $47.32 |
| 52 Week High | $127.56 | $87.32 |
| Indicator | ITGR | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 51.19 |
| Support Level | $83.08 | $48.47 |
| Resistance Level | $87.54 | $67.63 |
| Average True Range (ATR) | 3.67 | 1.93 |
| MACD | -0.14 | 1.15 |
| Stochastic Oscillator | 21.11 | 85.26 |
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.